References
- Tan EM. Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv Immunol. 1989;44:93–151.
- Hamaguchi Y, Hasegawa M, Fujimoto M, Matsushita T, Komura K, Kaji K, et al. The clinical relevance of serum antinuclear antibodies in Japanese patients with systemic sclerosis. Br J Dermatol. 2008;158(3):487–95.
- Maniotis A, Schliwa M. Microsurgical removal of centrosomes blocks cell reproduction and centriole generation in BSC-1 cells. Cell. 1991;67(3):495–504.
- Brenner S, Pepper DA, Turner DS, Boyd AE, Brinkley BR. Autoantibodies in human serum selectively bind to the centriole region in cultured cells. J Cell Biol. 1980;87(2):240a.
- Moroi Y, Murata I, Takeuchi A, Kamatani N, Tanimoto K, Yokohari R. Human anticentriole autoantibody in patients with scleroderma and Raynaud's phenomenon. Clin. Immunol. Immunopathol. 1983; 29(3):381.
- Osborn TG, Patel NJ, Ross SC, Bauer NE. Antinuclear antibody staining only centrioles in a patient with scleroderma. N Engl J Med. 1982;307(4):253–4.
- Tuffanelli DL, McKeon F, Kleinsmith DM, Burnham TK, Kirschner M. Anticentromere and anticentriole antibodies in the scleroderma spectrum. Arch Dermatol. 1983;119(7):560–6.
- Osborn TG, Ryerse JS, Bauer NE, Urhahn JM, Blair D, Moore TL. Anticentriole antibody in a patient with progressive systemic sclerosis. Arthritis Rheum. 1986;29(1):142–6.
- Sato S, Fujimoto M, Ihn H, Takehara K. Antibodies to centromere and centriole in scleroderma spectrum disorders. Dermatology. 1994;189(1):23–6.
- Stupi AM, Steen VD, Owens GR, Barnes EL, Rodnan GP, Medsger TA Jr. Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis. Arthritis Rheum. 1986;29(4):515–24.
- Steen VD. Autoantibodies in systemic sclerosis. Semin Arthritis Rheum. 2005;35(1):35–42.
- Steen VD, Powell DL, Medsger TA Jr. Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis. Arthritis Rheum. 1988;31(2):196–203.
- Hayakawa I, Sato S, Hasegawa M, Echigo T, Takehara K. A case of scleroderma spectrum disorder with anticentriole antibody and pulmonary hypertension. Clin Rheumatol. 2004;23(3):266–8.
- Kuwana M, Kaburaki J, Mimori T, Tojo T, Homma M. Autoantibody reactive with three classes of RNA polymerases in sera from patients with systemic sclerosis. J. Clin. Invest. 1993;91(4):1399–404.
- Kuwana M, Kaburaki J, Okano Y, Tojo T, Homma M. Clinical and prognostic associations based on serum antinuclear antibodies in Japanese patients with systemic sclerosis. Arthritis Rheum. 1994;37(1):75–83.
- Nakajima K, Kawano M, Kinuya K, Sato S, Takehara K, Tonami N. The diagnostic value of oesophageal transit scintigraphy for evaluating the severity of oesophageal complications in systemic sclerosis. Nucl Med Commun. 2004;25(4):375–81.
- LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, et al. Scleroderma (systemic sclerosis): classification, subsets, and pathogenesis. J. Rheumatol. 1988;15(2):202–5.
- LeRoy EC, Medsger TA Jr. Criteria for the classification of early systemic sclerosis. J Rheumatol 2001;28(7):1573–6.
- Rattner JB, Martin L, Waisman DM, Johnstone SA, Fritzler MJ. Autoantibodies to the centrosome (centriole) react with determinants present in the glycolytic enzyme enolase. J Immunol 1991;146(7):2341–4.
- Kuwana M, Okano Y, Kaburaki J, Tojo T, Medsger TA Jr. Racial differences in the distribution of systemic sclerosis-related serum antinuclear antibodies. Arthritis Rheum. 1994;37(6):902–6.
- Hofstee HM, Vonk Noordegraaf A, Voskuyl AE, Dijkmans BA, Postmus PE, Smulders YM, Serné EH. Nailfold capillary density is associated with the presence and severity of pulmonary arterial hypertension in systemic sclerosis. Ann Rheum Dis. 2009; 68(2):191–5.